TPBG

TPBG 詳細

英語名Trophoblast glycoprotein市販薬剤の数0
治験薬の数16ターゲットの別称Trophoblast glycoprotein,5T4 oncotrophoblast glycoprotein,5T4,TPBG,5T4 oncofetal antigen,M6P1,5T4 oncofetal trophoblast glycoprotein,Wnt-Activated Inhibitory Factor 1,WAIF1,5T4AG,5T4-AG
研究&開発段階Phase 2 Clinical
英語名Trophoblast glycoprotein
ターゲットの別称Trophoblast glycoprotein,5T4 oncotrophoblast glycoprotein,5T4,TPBG,5T4 oncofetal antigen,M6P1,5T4 oncofetal trophoblast glycoprotein,Wnt-Activated Inhibitory Factor 1,WAIF1,5T4AG,5T4-AG
市販薬剤の数0
治験薬の数16
研究&開発段階Phase 2 Clinical

TPBG 製品リスト

  • 属性

    Protein (9)Cell (1)Antibody (1)

  • 製品ライブラリ

    オンライン (10)研究中 (1)

  • Human (6)Cynomolgus / Rhesus macaque (1)Mouse (2)Rat (1)Rabbit (1)

  • タグ

    His Tag & Avi Tag (2)Fc Tag (2)His Tag (4)Fc Tag & Avi Tag (1)- (2)

  • マーカー

    Biotin-labeled (2)Unconjugated (8)- (1)

TPBGバックグランド

Trophoblast glycoprotein (TPBG), also known as 5T4, is the therapeutic target of several anticancer agents currently in clinical development, largely due to its high expression in tumors and low expression in normal adult tissues.This gene encodes a leucine-rich transmembrane glycoprotein that may be involved in cell adhesion. TPBG is expressed by all types of trophoblasts as early as 9 weeks of development.

TPBG分子の別称

TPBG,5T4,M6P1,5T4AG,WAIF1,5T4 oncofetal antigen,Trophoblast glycoprotein,5T4 oncofetal trophoblast glycoprotein

抗体購入プラットフォーム

プロジェクトステージタイプ由来疾患領域適応症
5T4 mAb - 01LeadMonoclonalHumanized MouseSolid TumorOvarian cancer,Lung cancer

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Naptumomab estafenatoxTTS-CD3; ABR-217620Phase 2 ClinicalActive Biotech AbBreast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Melanoma; Mesothelioma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
詳細
ALG.APV-527ALG.APV 527; ADC-1016; ATOR-1016; ALG.APV-527; ALG-APV-527Phase 2 ClinicalAlligator Bioscience Ab, Aptevo Therapeutics IncNeoplasms; Solid tumours
詳細
JK-06JK-06Phase 2 ClinicalXinlitai (Chengdu) Biological Technology Co LtdNeoplasms; Solid tumours
詳細
TUB-030TUB-030Phase 2 ClinicalTubulis GmbHCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
詳細
ACR-246ACR246; ACR-246; ADC2154; ADC-2154Phase 2 ClinicalHangzhou Adcoris Biopharmacy Co LtdBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Esophageal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Uterine Cervical Neoplasms
詳細
IBR-854IBR854; IBR-854Phase 2 ClinicalImbioray (Hangzhou) Biomedicine Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Solid tumours
詳細
SYD-1875SYD-1875Phase 1 ClinicalSynthon BvSolid tumours
詳細
ASN-004ASN-004Phase 1 ClinicalAsana Biosciences LlcSolid tumours
詳細
anti-5T4 CAR NK-cell therapy (Wuxi Peapole's Hospital/Hangzhou Yingbairui Biomedical Technology)Phase 1 ClinicalImbioray (Hangzhou) Biomedicine Co LtdSolid tumours
詳細
Naptumomab estafenatox/DurvalumabNTX-352Phase 1 ClinicalNeotx Therapeutics LtdSolid tumours
詳細
XB-010XB-010Phase 1 ClinicalExelixis IncBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal Squamous Cell Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
詳細
FTL-008.16FTL-008.16; FTL008.16Phase 1 ClinicalSound(Chengdu)Biopharmacauticals Co LtdSolid tumours
詳細
CBA-1535CBA-1535Phase 1 ClinicalChiome Bioscience IncCarcinoma, Non-Small-Cell Lung; Mesothelioma; Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Triple Negative Breast Neoplasms
詳細
Anti-5T4 CAR-raNK Cell TherapyPhase 1 ClinicalImbioray (Hangzhou) Biomedicine Co LtdSolid tumours
詳細
Prostate cancer vaccine(inactivated viral)(University of Oxford)ClinicalUniversity Of OxfordProstatic Neoplasms
詳細
68Ga-NOTA-H006ClinicalHuashan HospitalSolid tumours
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8